Development and Evaluation of a Physiologically Based Pharmacokinetic Drug-Disease Model of Propranolol for Suggesting Model Informed Dosing in Liver Cirrhosis Patients

AIM: The study was aimed to understand the underlying causes for the differences in propranolol pharmacokinetics (PK) between healthy and cirrhosis populations by using a systematic whole-body physiologically based pharmacokinetic (PBPK) model-building approach for suggesting model informed proprano...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalam, Muhammad Nasir, Rasool, Muhammad Fawad, Alqahtani, Faleh, Imran, Imran, Rehman, Asim Ur, Ahmed, Naveed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982780/
https://www.ncbi.nlm.nih.gov/pubmed/33762817
http://dx.doi.org/10.2147/DDDT.S297981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982780/
https://www.ncbi.nlm.nih.gov/pubmed/33762817
http://dx.doi.org/10.2147/DDDT.S297981

Ejemplares similares